Stay updated on Dapagliflozin Effects on Heart in Diabetes Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the effects of dapagliflozin on cardiac substrate uptake, myocardial efficiency, and myocardial contractile work in Type 2 Diabetes patients.
    Difference
    0.1%
    Check dated 2024-06-06T14:42:57.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for study participants, including specific health conditions and prior treatments required for inclusion. The new criteria emphasize the need for informed consent and compliance with study protocols.
    Difference
    36%
    Check dated 2024-05-22T21:33:19.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:35:26.000Z thumbnail image

Stay in the know with updates to Dapagliflozin Effects on Heart in Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.